BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,217,929 | -34.7% | 164,757 | -21.2% | 0.08% | -30.4% |
| Q2 2023 | $9,523,624 | +12.3% | 209,035 | -0.0% | 0.11% | +7.7% |
| Q1 2023 | $8,479,383 | -24.0% | 209,058 | -4.5% | 0.10% | -24.6% |
| Q4 2022 | $11,163,081 | -12.4% | 219,013 | -7.4% | 0.14% | -13.2% |
| Q3 2022 | $12,740,000 | -33.0% | 236,539 | -20.1% | 0.16% | -26.0% |
| Q2 2022 | $19,022,000 | -12.0% | 296,157 | +6.2% | 0.22% | +0.5% |
| Q1 2022 | $21,627,000 | -9.7% | 278,910 | -0.0% | 0.21% | -6.6% |
| Q4 2021 | $23,952,000 | +1.8% | 279,036 | -4.6% | 0.23% | -6.5% |
| Q3 2021 | $23,528,000 | -0.2% | 292,528 | -0.1% | 0.24% | +1.2% |
| Q2 2021 | $23,570,000 | -4.7% | 292,799 | -0.1% | 0.24% | -9.7% |
| Q1 2021 | $24,723,000 | +5.1% | 293,138 | -0.0% | 0.27% | +3.9% |
| Q4 2020 | $23,530,000 | -0.3% | 293,250 | -0.1% | 0.26% | -5.5% |
| Q3 2020 | $23,596,000 | -7.1% | 293,414 | -0.5% | 0.27% | -9.0% |
| Q2 2020 | $25,400,000 | -1.6% | 295,007 | -7.2% | 0.30% | -5.4% |
| Q1 2020 | $25,807,000 | -2.8% | 317,857 | +0.1% | 0.32% | +21.0% |
| Q4 2019 | $26,561,000 | -6.9% | 317,643 | -2.6% | 0.26% | -9.0% |
| Q3 2019 | $28,534,000 | -7.1% | 326,216 | -13.0% | 0.29% | +3.6% |
| Q2 2019 | $30,719,000 | -10.5% | 375,074 | -11.2% | 0.28% | -8.9% |
| Q1 2019 | $34,337,000 | +20.4% | 422,299 | -2.6% | 0.30% | +13.0% |
| Q4 2018 | $28,524,000 | -14.7% | 433,362 | -0.1% | 0.27% | -3.9% |
| Q3 2018 | $33,441,000 | +4.3% | 433,793 | -0.1% | 0.28% | -1.1% |
| Q2 2018 | $32,074,000 | +9.1% | 434,367 | -3.9% | 0.28% | +8.8% |
| Q1 2018 | $29,399,000 | +5.9% | 452,019 | +5.3% | 0.26% | +10.6% |
| Q4 2017 | $27,751,000 | +8.2% | 429,311 | +5.0% | 0.24% | +6.3% |
| Q3 2017 | $25,655,000 | +0.2% | 408,844 | -3.4% | 0.22% | -3.5% |
| Q2 2017 | $25,615,000 | +4.9% | 423,109 | -10.2% | 0.23% | +2.7% |
| Q1 2017 | $24,426,000 | +13.8% | 471,005 | -2.7% | 0.22% | +11.4% |
| Q4 2016 | $21,462,000 | -12.9% | 484,031 | -6.5% | 0.20% | -7.8% |
| Q3 2016 | $24,631,000 | -11.5% | 517,453 | -15.9% | 0.22% | -8.8% |
| Q2 2016 | $27,835,000 | +40.9% | 615,548 | +28.0% | 0.24% | +39.8% |
| Q1 2016 | $19,752,000 | +14.2% | 480,829 | +6.0% | 0.17% | +17.9% |
| Q4 2015 | $17,302,000 | +15.9% | 453,524 | -0.2% | 0.14% | +9.0% |
| Q3 2015 | $14,932,000 | -53.4% | 454,562 | -0.8% | 0.13% | -50.2% |
| Q2 2015 | $32,041,000 | +1.8% | 458,193 | -0.3% | 0.27% | +2.3% |
| Q1 2015 | $31,476,000 | -6.7% | 459,498 | -0.1% | 0.26% | -6.1% |
| Q4 2014 | $33,726,000 | -19.9% | 460,175 | -21.6% | 0.28% | -16.3% |
| Q3 2014 | $42,118,000 | -1.4% | 586,843 | -0.7% | 0.33% | -0.6% |
| Q2 2014 | $42,724,000 | -2.5% | 590,929 | -0.7% | 0.33% | -5.9% |
| Q1 2014 | $43,805,000 | -4.6% | 595,341 | -9.8% | 0.36% | -3.3% |
| Q4 2013 | $45,914,000 | +5.5% | 660,162 | -0.3% | 0.37% | -0.8% |
| Q3 2013 | $43,511,000 | -7.7% | 662,368 | -2.7% | 0.37% | -9.8% |
| Q2 2013 | $47,139,000 | – | 680,518 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |